Management delle vulvovaginiti- II parte
ESAME MICROSCOPICO A FRESCO DEI CAMPIONI Nell’infezione da Gardnerella vaginal is evidenziano, in gran numero, le caratteristiche “clue cells” (“cellule a traccia”) ossia cellule di desquamazione dell’epitelio vaginale cariche di elementi batterici di piccole dimensioni, oltre a molti piccoli coccobacilli e pochi leucociti. Tipico reperto di Candidosi e la presenza di spore. Semplice è anche […]
Ruolo dei sali d’ammonio quaternari nel trattamento delle vaginosi batteriche
Le Vaginosi Batteriche (VB) costituiscono un eterogeneo gruppo di patologie flogistiche del tratto genitale inferiore ad eziologia polimicrobica batterica caratterizzate da alterazioni dell’ecosistema vaginale con sostituzione della normale flora lattobacillare da parte di microorganismi patogeni (De Palo, 1993). Scopo del nostro lavoro è stato quello di valutare l’efficacia terapeutica di una nuova lavanda vaginale contenente […]
Serum oestradiol/FSH ratio to predict poor responders among patients undergoing IVF and ICSI
C. Manna, A. Rahman, G. Grimaldi, V. Unfer, H. Sallam. Genesis Ctr for Human Reproduction, Rome, Italy; Alexandria Fertility Ctr, Alexandria, Egypt. Objective: The aim of this work was to evaluate the plasma E2/FSH ratio as an index of ovarian stimulation response and a predictor of poor response in patients undergoing IVF and ICSI treatment, […]
Serum oestradiol FSH ratio to predict poor responders among patients undergoing IVF and ICSI
Objective: The aim of this work was to evaluate the plasma E2/FSH ratio as an index of ovarian stimulation response and a predictor of poor response in patients undergoing IVF and ICSI treatment, compared to plasma E2 or FSH alone. Design: Stepwise regression analysis in a group of patients attending ART procedures in year 2000. […]
Low Dose of Ethinyl Estradiol Can Reverse the Antiestrogenic Effects of Clomiphene Citrate
Fifty healthy, voluntary patients aged between 20 and 30 years with regular menstruation and plasmatic progesterone level 110 ng/ml at the midluteal phase have been enrolled in this study. They were randomly treated with clomiphene citrate (CC; group A) or CC + ethinyl estradiol (0.05 mg group B, or 0.02 mg group C). We estimated […]
Low Dose of Ethinyl Estradiol Can Reverse the Antiestrogenic Effects of Clomiphene Citrate
Fifty healthy, voluntary patients aged between 20 and 30 years with regular menstruation and plasmatic progesterone level 110 ng/ml at the midluteal phase have been enrolled in this study. They were randomly treated with clomiphene citrate (CC; group A) or CC + ethinyl estradiol (0.05 mg group B, or 0.02 mg group C). We estimated […]
Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination
Objective: To compare the effectiveness of clomiphene citrate used alone and in combination with ethinyl E2 for the induction of ovulation in patients undergoing IUI. Design: Randomized, double-blind study. Setting: Four infertility treatment centers. Patient(s): Women aged 25–35 years with infertility of at least 2 years’ duration and oligomenorrhea or amenorrhea associated with a positive […]
Use of Intramuscular Progesterone versus Intravenous Albumin for the Prevention of Ovarian Hyperstimulation Syndrome
This study was designed to compare the effectiveness of intramuscular progesterone with that of intravenous albumin in the prevention of ovarian hyperstimulation syndrome (OHSS). Ninety-six patients at high risk to develop OHSS (estradiol concentration 19,000 pmol/l on the day of hCG administration and over 20 follicles of a diameter larger than 14 mm observed by […]
Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study
To compare the effectiveness of clomiphene citrate used alone and in combination with ethinyl E2 for the induction of ovulation in patients undergoing IUI Scarica il documento
Trattamento della ipercontrattilità uterina in gravidanza e riduzione del rischio di parto prematuro
La prematurità rimane la principale causa di morte perinatale in bambini non malformati. II parto prematuro ha una incidenza del 6-10% ma è responsabile di oltre il 60% < della mortalità perinatale. Tale incidenza di parto prematuro negli ultimi 10 anni a dispetto dell a disponibilità di numerosi agenti tocolitici e rimasta invariata. Vi sono […]